Skip to main content
Veterinary Medicines

C-B-Gluconat plus BG

Authorised
  • Calcium gluconate
  • Magnesium chloride
  • Boric acid

Product identification

Medicine name:
C-B-Глюконат плюс БГ
C-B-Gluconat plus BG
Active substance:
  • Calcium gluconate
  • Magnesium chloride
  • Boric acid
Target species:
  • Horse
  • Cattle
  • Sheep
  • Goat
  • Pig
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Calcium gluconate
    240.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride
    60.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Boric acid
    60.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
    • Cattle
    • Sheep
    • Goat
    • Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-2929
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 28/06/2023

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 7/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."